<ARTICLE> 5
<LEGEND>
This schedule contains summary information extracted from Intel Corporation's
CONSOLIDATED CONDENSED STATEMENTS OF INCOME AND CONSOLIDATED CONDENSED BALANCE
SHEETS and is qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000,000

                             
<PERIOD-TYPE>                   6-MOS
<FISCAL-YEAR-END>                          DEC-26-1998
<PERIOD-END>                               JUN-27-1998
<CASH>                                            1887
<SECURITIES>                                      5811
<RECEIVABLES>                                     3126<F3>
<ALLOWANCES>                                         0
<INVENTORY>                                       1703
<CURRENT-ASSETS>                                 13368
<PP&E>                                           20303
<DEPRECIATION>                                    8300
<TOTAL-ASSETS>                                   28418
<CURRENT-LIABILITIES>                             4254
<BONDS>                                            472
<PREFERRED-MANDATORY>                              711<F1>
<PREFERRED>                                          0
<COMMON>                                          4853
<OTHER-SE>                                       16880
<TOTAL-LIABILITY-AND-EQUITY>                     28418
<SALES>                                          11928
<TOTAL-REVENUES>                                 11928
<CGS>                                             5776
<TOTAL-COSTS>                                     5776
<OTHER-EXPENSES>                                  1383<F2>
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                  15
<INCOME-PRETAX>                                   3731
<INCOME-TAX>                                      1286
<INCOME-CONTINUING>                               2445
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                      2445
<EPS-PRIMARY>                                     1.47<F4>
<EPS-DILUTED>                                     1.38

<FN>
<F1>Item consists of put warrants.
<F2>Item consists of research and development, including $165 million
    for purchased in-process research and development.
<F3>Item shown net of allowance, consistent with the balance sheet
    presentation.
<F4>Item consists of basic earnings per share
</FN>